Neural Bases of Post-stroke Emotion Perception Disorders
NCT ID: NCT05595005
Last Updated: 2025-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2024-02-16
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Imaging of the Brain in Emotional Processing
NCT00061204
fMRI Study of Brain Mechanisms Related to Emotions
NCT02939885
REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
NCT03504709
Stimulation-Induced Changes in Fronto-Limbic Network
NCT05854160
Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Voluntary Patients
NCT03160235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke
Stroke patients (ischemic or hemorrhagic) in the chronic phase (\> 6 months)
No interventions assigned to this group
Healthy controls
Healthy adult controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Man or Woman
* Age 18-80y
* Unique stroke, ischemic or hemorrhagic
* at the chronic phase (\< 6 months)
* Written informed consent
* subject having a social insurance
* Subject who consent to complete all the study's experiments
Healthy controls group:
* Man or Woman
* Age 18-80y
* No history of neurological or psychiatric disease.
Exclusion Criteria
* Subject who is unable to consent (due to dementia, severe aphasia, psychiatric disorder...)
* History of other neurologic disorders
* Significant le vel of depression or anxiety, assessed by the STAI and the BDI questionnaires
* Non corrected visual loss
* Subjects suffering from visual neglect (assessed by the Bells Test and a bisection test (20mm)
* contra-indications to MRI
* pregnant or breastfeeding woman
* Women of childbearing age without effective contraception
Healthy controls group
* Subject who is unable to consent (due to dementia, severe aphasia, psychiatric disorder...)
* History of neurologic disorders
* Significant level of depression or anxiety, assessed by the STAI and the BDI questionnaires
* Non-corrected visual loss
* contra-indications to MRI
* pregnant or breastfeeding woman
* Women of childbearing age without effective contraception
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupement Interrégional de Recherche Clinique et d'Innovation
OTHER
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Etienne Allart, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Swynghedauw
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Etienne Allart
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A00193-36
Identifier Type: OTHER
Identifier Source: secondary_id
2019_12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.